Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infant, Premature: full-pipeline trial registry
2 of 17 indexed Infant, Premature trials are currently recruiting.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 2 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Infant, Premature: 17 US clinical trials tracked, 2 recruiting.
Infant, Premature is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is NICHD Neonatal Research Network, running 12 of these trials.
Enrollment posture brief
Registry condition infant-premature
OPEN 2 | RECR 12% | LATE 3 | EARLY 2 | RANK #1004 | SPON 12
Volume-matched condition peers
Nearest open-share peer: Gestational Diabetes Mellitus (12% recruiting · 17 trials)
Infant, Premature lists 2 open slots (12% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Infant, Premature on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Infant, Premature is recruiting below its size-band peers.
2 of 17 indexed trials (11.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Infant, Premature research.
NICHD Neonatal Research Network accounts for 12 of 17 trials (70.6%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Infant, Premature enrolment sits around 800 participants.
Median target enrolment is 800 among the 17 trials that report a genuine target (sentinel values excluded). 3 of those (17.6%) plan for fewer than 100 participants.
-
Infant, Premature splits between interventional and observational designs.
9 interventional and 8 observational studies make up this index (52.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Generic Database of Very Low Birth Weight Infants
NICHD Neonatal Research Network
NCT00063063
Follow-up Visit of High Risk Infants
NICHD Neonatal Research Network
NCT00009633
Management of the PDA Trial
NICHD Neonatal Research Network
NCT03456336
Serial Assessment of Body Fat Accrual in Very Preterm Infants
University of Alabama at Birmingham
NCT03575897
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
NICHD Neonatal Research Network
NCT01203345
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
NICHD Neonatal Research Network
NCT00005775
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
NICHD Neonatal Research Network
NCT01203501
Development of Standards for the New Ballard Maturation Score
NICHD Neonatal Research Network
NCT01203449
Inflammatory Cytokines Associated With Perinatal Brain Injury
NICHD Neonatal Research Network
NCT01035697
Hydrocortisone for BPD
NICHD Neonatal Research Network
NCT01353313
Physiologic Definition of Bronchopulmonary Dysplasia
NICHD Neonatal Research Network
NCT01223287
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
University of Texas Southwestern Medical Center
NCT02064712
Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates
University of Alabama at Birmingham
NCT02377050
Delivery Room CPAP in Extremely Low Birth Weight Infants
NICHD Neonatal Research Network
NCT01223274
Cerebral Function Monitoring in Premature Infants
NICHD Neonatal Research Network
NCT00873847
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
University of Utah
NCT03551600
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2
University of Alabama at Birmingham
NCT03333161
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Infant, Premature records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Infant, Premature trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Infant, Premature page
17 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Infant, Premature trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NICHD Neonatal Research Network sponsors the most Infant, Premature trials on record, review their full trial history before evaluating a specific study. See NICHD Neonatal Research Network's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infant, Premature condition card totals 17 registered trials; most-linked intervention Placebo; top US site state Alabama. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.